Prelude Capital Management’s Alkermes ALKS Stock Holding History

Prelude Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,900	Closed	-$590K	–	1751
2018 Q3	$590K	Buy	+13,900	New	+$603K	0.03%	484

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Prelude Capital Management's ALKS Position: Q2 2026 in Review

Prelude Capital Management sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 16,928 shares — an estimated $599K sold.

Prelude Capital Management first reported a position in ALKS in Q3 2013 and held it in 12 quarters. The position peaked at $652K in Q4 2015. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Prelude Capital Management reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
Prelude Capital Management sold 16,928 Alkermes shares in Q2 2026, an estimated $599K.
Prelude Capital Management first reported a position in Alkermes in Q3 2013 and held it in 12 quarters.
Prelude Capital Management's Alkermes position peaked at $652K in Q4 2015.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.